Showing results (21-30 of 290) with videos related to
Sort By:
Pageof 29
The Journal of Infectious Diseases|August 31, 2016
Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman PrimatesChad E Mire, Joan B Geisbert, Krystle N Agans, et al.Mbio|November 6, 2014
Deep sequencing identifies noncanonical editing of Ebola and Marburg virus RNAs in infected cellsReed S Shabman, Omar J Jabado, Chad E Mire, et al.The Journal of Infectious Diseases|June 28, 2023
The Mucin-Like Domain of the Ebola Glycoprotein Does Not Impact Virulence or Pathogenicity in FerretsPeter J Halfmann, Viktoriya Borisevich, Corri B Levine, et al.Current Opinion in Virology|August 12, 2019
Antibody therapy for Lassa feverRobert W Cross, Kathryn M Hastie, Chad E Mire, et al.Emerging Infectious Diseases|May 21, 2019
Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus DiseaseChad E Mire, Joan B Geisbert, Krystle N Agans, et al.Methods in Molecular Biology (Clifton, N.J.)|August 23, 2023
Ferret Models for Henipavirus InfectionBarry Rockx, Chad E MirePlos Neglected Tropical Diseases|March 27, 2012
Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primatesChad E Mire, Andrew D Miller, Angela Carville, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 4, 2019
Current Ebola Virus Vaccine ProgressAndrea Marzi, Chad E MireMicroorganisms|March 26, 2022
Hemorrhagic Fever Viruses: Pathogenesis and CountermeasuresChad E Mire, Andrea MarziScientific Reports|May 9, 2019
Author Correction: Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variantsKrista Versteeg, Andrea R Menicucci, Courtney Woolsey, et al.Pageof 29